Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Infliximab

5

XII.d Myocarditis (can be fulminant)

1
Last update : 14/12/2019
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Biosimilars
1
Infliximab biosimilar
1
TNF-alpha antagonists / inhibitors
5

Publications

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.
Cureus 2022 Jun;14;e26366 2022 Jun
[Childhood Interstitial Lung Disease in Infancy. Classification, diagnosis and management].
Archivos argentinos de pediatria 2019 Apr;117;S120-S134 2019 Apr
Hypersensitivity perimyocarditis after the first dose of infliximab.
Revista espanola de enfermedades digestivas 2015 Apr;107;249 2015 Apr
Myocarditis associated with infliximab: a case report and review of the literature.
Inflammatory bowel diseases 2011 Jul;17;1633-4 2011 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies